跳至主要内容
临床试验/NL-OMON54294
NL-OMON54294撤回不适用

Prospective multicentre clinical trial with the Artiflex Presbyopic, an iris-fixated multifocal intraocular lens for the correction of presbyopia in phakic eyes - Clinical Trial With Artiflex Presbyopic

OPHTEC BV0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
OPHTEC BV
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Presbyopic adult
  • Potential for binocular vision
  • Subject wishes to be spectacle independent for near and far vision
  • Refractive error that can be corrected with correction at PIOL plane from +2.0
  • to -15.0 D
  • Subject requiring a presbyopic correction
  • Patients with reading glasses of minimum +1D.
  • Stable refraction (±0.75 D), as expressed by manifest refraction spherical
  • equivalent (MRSE) for a minimum of 12 months prior to surgery, verified by
  • consecutive refractions and/or medical records or prescription history
  • Expected best corrected visual acuity of 0.2 logMAR (0.63 Snellen decimal) or
  • better after lens implantation
  • Current contact lens wearer should demonstrate a stable refraction (± 0.5 D),
  • expressed as subjective refraction spherical equivalent, on two consecutive
  • examination dates performed at least 7 days apart. Before the first
  • refraction, the contact lens wearer should not have worn lenses for at least 2
  • weeks in case of rigid and toric contact lenses, or 3 days for spherical soft
  • contact lenses.
  • Any subject, who is expected to have a residual postoperative cylindrical
  • refractive error of below 0.75 D
  • Ability to give informed consent
  • Availability, willingness and sufficient cognitive awareness and physical
  • ability to comply with examination procedures throughout the entire duration of

排除标准

  • Preoperative ocular or systemic condition or medication use that would be
  • expected to present undue risk to the subject, that can predispose for future
  • complications or confound the outcome(s) of the study.
  • E.g. the systemic use of alpha-1a adrenergic receptor antagonists was suggested
  • to increase the occurrence of intraoperative floppy iris syndrome, alter iris
  • morphology - or more specifically reduce iris thickness at the site of
  • potential IOL enclavation - and increase postoperative endothelial cell loss.
  • Previous ocular surgery which might affect the outcome of the study
  • Concurrent participation or participation during the last 30 days in another
  • drug or device investigation
  • Subjects with a distance corrected near visual acuity of better than 20/60 or
  • 0.48 LogMAR.
  • Secondary surgical procedure planned during the first 6 months of the study
  • (e.g. laser treatment to correct astigmatism)
  • Preoperative anterior chamber depth measurement of below 3.0 mm for subjects <
  • 40 years old and 2.8 mm for subjects > 40 years old. Anterior chamber depth is
  • measured from the corneal endothelium to the anterior pole of the crystalline
  • lens. This will result in a critical distance between PIOL and endothelium of
  • 1.5 mm or more as simulated with anterior segment imaging.
  • White-to-white smaller than 10.5 mm
  • Subjects not meeting the age specific minimum preoperative endothelial cell
  • density as defined below:
  • 31 to 35 years of age 2400 cells/mm2;
  • 36 to 45 years of age 2200 cells/mm2;
  • > 45 years of age 2000 cells/mm2
  • Corneas with high rates of polymegethism (a coefficient of variation over
  • 0.40) and pleomorphism (the presence of less than 50% hexagonal cells).
  • Abnormal iris (e.g. convex, bulging or volcano shaped iris)
  • Crystalline lens rise of 600 µm or more
  • Abnormal cornea (keratoconus, opaque cornea, corneal scars, post corneal
  • transplant, corneal dystrophy, or other)
  • Ocular surface conditions which might influence the quality of vision and
  • affect the outcome of the study
  • Abnormal pupil (e.g. nonreactive, fixed)
  • Ectopic pupil
  • Pupil in photopic light conditions smaller than 2.6 mm
  • Pupil in scotopic light conditions greater than 7.0 mm
  • High preoperative intraocular pressure (>21 mm Hg)
  • Cataract of any grade
  • Glaucoma or family history of glaucoma (dependent on the evaluation of
  • Diabetes or diabetic retinopathy
  • Acute or chronic inflammation
  • Chronic or recurrent uveitis or family history of the same condition
  • Retinal detachments or family history of retinal detachments
  • Corticosteroid responder
  • Pregnant or nursing
  • Aged under 18

研究者

发起方
OPHTEC BV

相似试验